Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Durai B. Subramani
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded With a Combination of Vaccine and COX-2 Inhibition
Journal of Immunology
Allergy
Immunology
Related publications
Simultaneous Targeting of 5-Lox-Cox and EGFR Blocks Progression of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Neoadjuvant Selective COX-2 Inhibition Downregulates Important Oncogenic Pathways in Patients With Esophageal Adenocarcinoma
European Journal of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Viscum Album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
PLoS ONE
Multidisciplinary
Inhibition of COX-2 Expression by Endocannabinoid 2-Arachidonoylglycerol Is Mediated via PPAR-γ
British Journal of Pharmacology
Pharmacology
Fibroblast Activation Protein Augments Progression and Metastasis of Pancreatic Ductal Adenocarcinoma
JCI insight
Medicine
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray
Modern Pathology
Forensic Medicine
Pathology
Synergistic Inhibition of the Growth of Adenocarcinoma 755 by the Combination of Interleukin-2 and Interferon-.Beta..
Proceedings of the Japan Academy Series B: Physical and Biological Sciences
Multidisciplinary
Biological Sciences
Medicine
Agricultural
Astronomy
Physics